BE trial design as partial replicate and two stage [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2014-04-17 11:17 (4454 d 16:00 ago) – Posting: # 12847
Views: 2,824

Hi Silva,

❝ Is it advisable to use two stage design approach in partial replicate design?

❝ If yes, which alpha level should be used for the second stage (combined stage I + stage II data)?


There are no publications about two-stage studies and replicated designs of any type. Therefore I would only attempt to do it after a scientific advice. They may ask you to prove by your own simulations if/how the method performs in various scenarios.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
322 visitors (0 registered, 322 guests [including 20 identified bots]).
Forum time: 03:18 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5